Doctors start giving second round of shots to volunteers in Seattle COVID-19 vaccine trial

Doctors start giving second round of shots to volunteers in Seattle COVID-19 vaccine trial

The Seattle volunteers who got shots in the first trial of a possible coronavirus vaccine are now getting the second shot — an indicator the early trial is progressing well.

While the doctors at Kaiser Permanente's Vaccine Treatment and Evaluation Unit in Seattle don’t know the results of the first round of tests, the fact that it has continued and that the second round of injections are now being given is good news, said Lisa Jackson, who is leading the study.

“The trial hasn’t been stopped. We know from the study protocol that if adverse events had happened, the protocol would have required that,” she said. “Therefore we presume those things haven’t happened.”

The volunteers are taking part in the first investigational vaccine study to fight coronavirus. The study launched on March 16.

The vaccine, called mRNA-1273, was developed by scientists at the National Institute of Allergy and Infectious Diseases and at the Cambridge, Mass.-based biotechnology company Moderna, Inc..

It is being given in two doses because the SARS-CoV-2 virus, which causes COVID-19, is new and no one had been exposed to it before it appeared in December, said Jackson.

Humans are a "naive" population when it comes to the virus. The first shot “is a primer to set the immune system up, giving it a first look at the virus,” Jackson said.

The second shot, administered 28 days later, builds on that protection so the body can more rapidly produce antibodies if it is later exposed to the virus.

After the first set of volunteers was enrolled in Seattle, the trial was expanded on March 27 to include volunteers at Emory University’ in Atlanta, Georgia. The initial group included 28 in Seattle and 17 at Emory.

The volunteers will be followed for 13 months to ensure they have no side effects or other reactions to the vaccine.

Jennifer Haller, left, smiles as the needle is withdrawn after she was given the first-stage safety study clinical trial of the potential vaccine.

The experimental Moderna vaccine uses messenger RNA to get the body’s own cells to produce a protein found on the “spikes” on the surface of the SARS-CoV-2 virus it uses to infect human cells.

The hope is that the body will respond to those proteins by mounting a robust immune response to the virus.

The National Institutes of health is now expanding the trial to include 60 adults over the age of 56, Jackson said. Some will be tested in Seattle, some in Atlanta at some at the NIH in Bethesda, Maryland.

The test is part of Phase I trial of the possible vaccine. The goal is to test the safety of various doses and whether these doses produce an immune response.

Phase I trials don’t study whether the vaccine is effective in preventing COVID-19 infection. That comes in Phase II.


News Related


Trump’s ‘mission accomplished’ moment is premature and deadly. We have not defeated COVID.

Desperate for crowds and adoration, Trump has put his most fervent supporters at risk of getting a deadly disease. Future historians will be astonished. Read more »

NFLPA president JC Tretter says NFL is putting season, players at risk with its coronavirus approach

NFL Players Association president JC Tretter said Tuesday the NFL is putting the 2020 season at risk with its coronavirus approach, calling on the league to better “prioritize player safety.” “Like many other... Read more »

Brazilian President Jair Bolsonaro says he tested positive for the coronavirus

RIO DE JANEIRO (AP) — Brazil’s President Jair Bolsonaro says he has tested positive for COVID-19 after months of downplaying the virus’ severity. Bolsonaro confirmed the test results while wearing a mask and... Read more »

Venice Film Festival forges ahead amid COVID-19 pandemic with reduced lineup

The show will go on for the Venice Film Festival in September, but with a few modifications due to the COVID-19 pandemic. Organizers said Tuesday that they are pushing forward with plans for... Read more »

Amtrak offers buy-one, get-one promotion on its sleeper trains amid COVID-19 — with a catch

Amtrak wants you to have sweet dreams the next time you travel — so much so that it’s sweetening the deal on its sleeper “roomettes.” The rail service is offering a buy-one-get-one-free discount... Read more »

Florida teen treated with hydroxychloroquine at home before dying of COVID-19, report says

FORT MEYERS, Fla. – The family of a 17-year-old Florida girl who died last month from COVID-19 treated her symptoms at home for nearly a week before taking her to a hospital, a... Read more »

Mookie Betts worried MLB coronavirus testing woes could prevent him from ever playing for Dodgers

During nearly four months away from the game, Mookie Betts said he “stayed away from baseball to keep myself sane.” It’s not hard to understand why. The 2018 American League Most Valuable Player... Read more »

Tom Hanks doesn’t get ‘how common sense has somehow been put into question’ with coronavirus

Read more »

Can Gov. DeSantis force Florida schools to reopen amid the coronavirus pandemic? Some school leaders seem doubtful.

PALM BEACH, Fla. — As concern about the state order spread online, some school leaders said: Not so fast. As Florida educators puzzle over how to start the new academic year, Gov. Ron... Read more »

Texas surpasses 200,000 coronavirus cases after 4th of July holiday weekend

AUSTIN, Texas – Texas reached 200,000 total COVID-19 cases Monday, just 17 days after crossing the 100,000 threshold, a figure that took the state nearly four months to hit. The grim milestone came... Read more »